Anouck Huijbers

1PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 16, 2018
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.

Anouck Huijbers, Gabi W van Pelt, Rachel S Kerr

Pageof 1

Frequent Collaborators